Role of secondary mediators in caffeine-mediated neuroprotection in maneb- and paraquat-induced Parkinson's disease phenotype in the mouse. (Q54540450)

31 May 2018

title

Role of secondary mediators in caffeine-mediated neuroprotection in maneb- and paraquat-induced Parkinson's disease phenotype in the mouse. (English)

1 reference

31 May 2018

1 reference

Sharawan Yadav

1

1 reference

31 May 2018

Satya Prakash Gupta

2

1 reference

31 May 2018

Garima Srivastava

3

1 reference

31 May 2018

Pramod Kumar Srivastava

4

1 reference

31 May 2018

Mahendra Pratap Singh

5

1 reference

31 May 2018

publication date

27 December 2011

1 reference

31 May 2018

published in

Neurochemical Research

1 reference

31 May 2018

volume

37

1 reference

31 May 2018

issue

4

1 reference

31 May 2018

page(s)

875-884

1 reference

31 May 2018

https://scigraph.springernature.com/pub.10.1007/s11064-011-0682-0

exact match

0 references

cites work

Parkinson's disease: clinical aspects

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb- and paraquat-induced Parkinson's disease phenotype in mouse: mechanism of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Nicotine- and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: Implications in neuroprotection mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Proteomics in Parkinson's disease: current trends, translational snags and future possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Gene expression profiles of mouse striatum in control and maneb + paraquat-induced Parkinson's disease phenotype: validation of differentially expressed energy metabolizing transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Involvement of nitric oxide in maneb- and paraquat-induced Parkinson's disease phenotype in mouse: is there any link with lipid peroxidation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Association of coffee and caffeine intake with the risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Systemic administration of adenosine A(2A) receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Nigrostriatal proteomics of cypermethrin-induced dopaminergic neurodegeneration: microglial activation-dependent and -independent regulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Arginine vasopressin modulates expression of neuronal NOS in rat renal medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Identification of differentially expressed proteins in striatum of maneb-and paraquat-induced Parkinson's disease phenotype in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

The role of microglia in paraquat-induced dopaminergic neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Microglial activation induced by neurodegeneration: a proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Microglial cells and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

NF-kappaB: a key role in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0682-0

Do environmental toxins cause Parkinson's disease? A critical review

21 January 2018

1 reference

12 December 2020

Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia

1 reference

12 December 2020

Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease

1 reference

12 December 2020

Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study

1 reference

12 December 2020

The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.

1 reference

12 December 2020

Paraquat and maneb induced neurotoxicity

1 reference

12 December 2020

Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons.

1 reference

12 December 2020

Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse

1 reference

12 December 2020

International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors

1 reference

12 December 2020

Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum

1 reference

12 December 2020

NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site.

1 reference

12 December 2020

Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease.

1 reference

12 December 2020

Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease

1 reference

12 December 2020

10.1007/S11064-011-0682-0

Identifiers

DOI

1 reference

31 May 2018

PubMed ID

22201039

1 reference

31 May 2018